These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Ramurthy S; Aikawa M; Amiri P; Costales A; Hashash A; Jansen JM; Lin S; Ma S; Renhowe PA; Shafer CM; Subramanian S; Sung L; Verhagen J Bioorg Med Chem Lett; 2011 Jun; 21(11):3286-9. PubMed ID: 21543226 [TBL] [Abstract][Full Text] [Related]
9. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage. Li Z; Yang Q; Qian X Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150 [TBL] [Abstract][Full Text] [Related]
10. Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors. Wu Z; Yang C; Graham TH; Verras A; Chabin RM; Xu S; Tong X; Xie D; Lassman ME; Bhatt UR; Garcia-Calvo MM; Shen Z; Chen Q; Bleasby K; Sinharoy R; Hale JJ; Tata JR; Pinto S; Colletti SL; Shen DM Bioorg Med Chem Lett; 2012 Feb; 22(4):1727-30. PubMed ID: 22290078 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors. Ramurthy S; Costales A; Jansen JM; Levine B; Renhowe PA; Shafer CM; Subramanian S Bioorg Med Chem Lett; 2012 Feb; 22(4):1678-81. PubMed ID: 22264479 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists. Martín-Martínez M; Bartolomé-Nebreda JM; Gómez-Monterrey I; González-Muñiz R; García-López MT; Ballaz S; Barber A; Fortuño A; Del Río J; Herranz R J Med Chem; 1997 Oct; 40(21):3402-7. PubMed ID: 9341915 [TBL] [Abstract][Full Text] [Related]
13. Research on heterocyclic compounds. XXXVIII. Synthesis and pharmacological activity of imidazo[1,2-b]pyridazine-2-carboxylic derivatives. Luraschi E; Arena F; Sacchi A; Laneri S; Abignente E; Avallone L; D'Amico M; Berrino L; Rossi F Farmaco; 1997 Apr; 52(4):213-7. PubMed ID: 9241825 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists. Kiyoi T; York M; Francis S; Edwards D; Walker G; Houghton AK; Cottney JE; Baker J; Adam JM Bioorg Med Chem Lett; 2010 Aug; 20(16):4918-21. PubMed ID: 20634067 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists. Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942 [TBL] [Abstract][Full Text] [Related]
20. The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonists. Napier S; Wishart G; Arbuckle W; Baker J; Barn D; Bingham M; Brown A; Byford A; Claxton C; Craighead M; Buchanan K; Fielding L; Gibson L; Goodwin R; Goutcher S; Irving N; MacSweeney C; Milne R; Mort C; Presland J; Sloan H; Thomson F; Turnbull Z; Young T Bioorg Med Chem Lett; 2011 May; 21(10):3163-7. PubMed ID: 21458261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]